Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the use of topical tofacitinib to promote hair
regrowth in patients with alopecia areata, alopecia totalis, and alopecia universalis.